Beylerli, Ozal,
Tamrazov, Rasim,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Bai, Yunlong,
Yang, Baofeng (2023) to play important roles in various aspects of TBI, such as neuroinflammation, blood-brain
barrierBeylerli, Ozal,
Gareev, Ilgiz,
Beilerli, Aferin,
Ilyasova, Tatiana,
Shi, Huaizhang,
Sufianov, Albert (2024) –brain
barrier, promotion of angiogenesis, and modulation of the immune response post-cerebral infarction
, and dysfunction of the blood-brain
barrier. Understanding the mechanisms underlying glutamate toxicity in MS may
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) is limited by their bioavailability and blood-brain
barrier permeability. Many of them have a significant
НАПРАВЛЕНИЕ РЕАКЦИИ 6-МЕТИЛПИРИМИДИН-2,4(1Н,3Н)-ДИОНА С 2-ХЛОРМЕТИЛТИИРАНОМ: N1- ИЛИ N3-ТИЕТАНИЛПРОИЗВОДНОЕ?KATAEV, V.A.,
MESHCHERYAKOVA, S.A.,
MESHCHERYAKOVA, E.S.,
TYUMKINA, T.V.,
KHALILOV, L.M.,
LAZAREV, V.V.,
KUZNETSOV, V.V.,
Катаев В.А.,
Мещерякова С.А.,
Мещерякова Е.С.,
Тюмкина Т.В.,
Халилов Л.М.,
Лазарев В.В.,
Кузнецов В.В. (2018) derivative is more stable than the N (1)-isomer. It was also found that the calculated
barrier to internal
Khazhiev, SY,
Khusainov, MA,
Khalikov, RA,
Kataev, VA,
Tyumkina, TV,
Meshcheryakova, ES,
Khalilov, LM,
Kuznetsov, VV (2021) of conformational transformations and the potential
barriers for internal rotation of aromatic and N(CH3)(2) groups
Sufianov, Albert,
Beilerli, Aferin,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Wenjie, Bu,
Beylerli, Ozal (2023) , susceptibility to degradation by nucleases, and difficulty in penetrating the skin
barrier. Effective delivery
Zivari-Ghader, Tayebeh,
Valioglu, Ferzane,
Eftekhari, Aziz,
Aliyeva, Immi,
Beylerli, Ozal,
Davran, Soodabeh,
Cho, William C.,
Beilerli, Aferin,
Khalilov, Rovshan,
Javadov, Sabzali (2024) of conventional treatments for patients with central nervous system diseases. The blood-brain
barrier prevents